Teresa Jose

Chief Audit Officer · Novartis

Pharmaceuticals

Teresa Jose is Novartis’s chief audit officer. Her earlier finance leadership includes business planning and digital finance, oncology finance and the UK country CFO role.

Last reviewed: Nov 15, 2026

Executive Summary

Teresa Jose is Novartis’s chief audit officer. Her earlier finance leadership includes business planning and digital finance, oncology finance and the UK country CFO role.

Career Highlights

  • Became chief audit officer on July 1, 2025.
  • Has worked at Novartis since 1990.
  • Previously held global planning, oncology CFO and UK CFO assignments.

Professional Journey

Jose joined Novartis in 1990 and built a finance career spanning corporate, divisional and country organizations. Her assignments have taken her across Asia, Europe and the United States.

Earlier leadership roles included country CFO for the United Kingdom and CFO for Oncology. She subsequently led global Business Planning & Analysis and Digital Finance. Her company biography credits her with acquisitions and integrations, finance transformation work and support for the Sandoz spin-off.

She became chief audit officer on July 1, 2025. The role provides risk-based assurance and advice to the board and management, drawing on her experience across the company’s financial and operational organizations.

Jose’s academic background includes an MBA identified with Columbia and London Business School and a bachelor’s degree from the University of Bombay. She is also a certified cost accountant.

Education

Master of Business Administration — Columbia Business School / London Business School.

Bachelor’s degree — University of Bombay.